Trial Outcomes & Findings for HIV Testing at Family Planning Clinics in Mombasa County, Kenya (NCT NCT02994355)

NCT ID: NCT02994355

Last Updated: 2023-11-30

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

24 participants

Primary outcome timeframe

Months 9-12 of the study

Results posted on

2023-11-30

Participant Flow

Unit of analysis: Family Planning Clinics

Participant milestones

Participant milestones
Measure
Intervention Clinics
Clinics randomized to the intervention will be introduced to the Systems Analysis and Improvement Approach (SAIA) to understand barriers to HIV testing in family planning clinics. Sequential process flow mapping will be used to highlight areas for improvement and then specific interventions will be implemented for the clinics with the goal of increasing HIV testing rates. Systems Analysis and Improvement Approach: 1. Understanding the cascade from FP clinic enrollment to HIV testing 2. Use process mapping to identify modifiable bottlenecks 3. Define and implement workflow adaptations to eliminate modifiable bottlenecks 4. Monitor change in performance 5. Repeat the analysis and improvement cycle (steps 1-4)
Control Clinics
Clinics randomized to the control arm of the study will continue HIV testing as per usual procedures.
Overall Study
STARTED
0 12
0 12
Overall Study
COMPLETED
0 11
0 11
Overall Study
NOT COMPLETED
0 1
0 1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

HIV Testing at Family Planning Clinics in Mombasa County, Kenya

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention Clinics
n=12 Family Planning Clinics
Clinics randomized to the intervention will be introduced to the Systems Analysis and Improvement Approach (SAIA) to understand barriers to HIV testing in family planning clinics. Sequential process flow mapping will be used to highlight areas for improvement and then specific interventions will be implemented for the clinics with the goal of increasing HIV testing rates. Systems Analysis and Improvement Approach: 1. Understanding the cascade from FP clinic enrollment to HIV testing 2. Use process mapping to identify modifiable bottlenecks 3. Define and implement workflow adaptations to eliminate modifiable bottlenecks 4. Monitor change in performance 5. Repeat the analysis and improvement cycle (steps 1-4)
Control Clinics
n=11 Family Planning Clinics
Clinics randomized to the control arm of the study will continue HIV testing as per usual procedures.
Total
n=23 Family Planning Clinics
Total of all reporting groups
Sex: Female, Male
Male
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
American Indian or Alaska Native
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
Asian
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Age, Categorical
<=18 years
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Age, Categorical
Between 18 and 65 years
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Age, Categorical
>=65 years
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Sex: Female, Male
Female
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
Black or African American
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
White
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
More than one race
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Race (NIH/OMB)
Unknown or Not Reported
NA Family Planning Clinics
n=12 Family Planning Clinics
NA Family Planning Clinics
n=11 Family Planning Clinics
NA Family Planning Clinics
n=23 Family Planning Clinics
Public Clinic
6 Family Planning Clinics
n=12 Family Planning Clinics
6 Family Planning Clinics
n=11 Family Planning Clinics
12 Family Planning Clinics
n=23 Family Planning Clinics
Urban Clinic
4 Family Planning Clinics
n=12 Family Planning Clinics
4 Family Planning Clinics
n=11 Family Planning Clinics
8 Family Planning Clinics
n=23 Family Planning Clinics
Complete auditory privacy
7 Family Planning Clinics
n=12 Family Planning Clinics
7 Family Planning Clinics
n=11 Family Planning Clinics
14 Family Planning Clinics
n=23 Family Planning Clinics
Complete visual privacy
8 Family Planning Clinics
n=12 Family Planning Clinics
6 Family Planning Clinics
n=11 Family Planning Clinics
14 Family Planning Clinics
n=23 Family Planning Clinics
FP clinic manager aware of most recent National HIV Guidelines
6 Family Planning Clinics
n=12 Family Planning Clinics
9 Family Planning Clinics
n=11 Family Planning Clinics
15 Family Planning Clinics
n=23 Family Planning Clinics
Number of FP providers trained in HTC
1 Family Planning Clinics
n=12 Family Planning Clinics
1 Family Planning Clinics
n=11 Family Planning Clinics
1 Family Planning Clinics
n=23 Family Planning Clinics
Clients required to pay for HIV testing
2 Family Planning Clinics
n=12 Family Planning Clinics
3 Family Planning Clinics
n=11 Family Planning Clinics
5 Family Planning Clinics
n=23 Family Planning Clinics

PRIMARY outcome

Timeframe: Months 9-12 of the study

Population: Data was collected at the clinic level.

Outcome measures

Outcome measures
Measure
Intervention Clinics
n=12 FP Clinics
Clinics randomized to the intervention will be introduced to the Systems Analysis and Improvement Approach (SAIA) to understand barriers to HIV testing in family planning clinics. Sequential process flow mapping will be used to highlight areas for improvement and then specific interventions will be implemented for the clinics with the goal of increasing HIV testing rates. Systems Analysis and Improvement Approach: 1. Understanding the cascade from FP clinic enrollment to HIV testing 2. Use process mapping to identify modifiable bottlenecks 3. Define and implement workflow adaptations to eliminate modifiable bottlenecks 4. Monitor change in performance 5. Repeat the analysis and improvement cycle (steps 1-4)
Control Clinics
n=11 FP Clinics
Clinics randomized to the control arm of the study will continue HIV testing as per usual procedures.
Percentage of Eligible (Not Known HIV+) New FP Clients Who Are Tested for HIV in the Months 9-12 of the Study in Intervention and Control Facilities
42 Percentage tested for HIV
Standard Deviation 26
32 Percentage tested for HIV
Standard Deviation 15

SECONDARY outcome

Timeframe: Months 9-12 of the study

Population: Data was collected at the clinic level.

Outcome measures

Outcome measures
Measure
Intervention Clinics
n=12 FP Clinics
Clinics randomized to the intervention will be introduced to the Systems Analysis and Improvement Approach (SAIA) to understand barriers to HIV testing in family planning clinics. Sequential process flow mapping will be used to highlight areas for improvement and then specific interventions will be implemented for the clinics with the goal of increasing HIV testing rates. Systems Analysis and Improvement Approach: 1. Understanding the cascade from FP clinic enrollment to HIV testing 2. Use process mapping to identify modifiable bottlenecks 3. Define and implement workflow adaptations to eliminate modifiable bottlenecks 4. Monitor change in performance 5. Repeat the analysis and improvement cycle (steps 1-4)
Control Clinics
n=11 FP Clinics
Clinics randomized to the control arm of the study will continue HIV testing as per usual procedures.
Percentage of New FP Clients Who Are Counseled About HIV Testing in the Months 9-12 of the Study in Intervention and Control Facilities, Adjusted for Baseline
85 Percentage counseled for HIV
Standard Deviation 27
67 Percentage counseled for HIV
Standard Deviation 34

SECONDARY outcome

Timeframe: Months 13-24 of the study

Population: Data was collected at the clinic level.

Outcome measures

Outcome measures
Measure
Intervention Clinics
n=12 FP Clinics
Clinics randomized to the intervention will be introduced to the Systems Analysis and Improvement Approach (SAIA) to understand barriers to HIV testing in family planning clinics. Sequential process flow mapping will be used to highlight areas for improvement and then specific interventions will be implemented for the clinics with the goal of increasing HIV testing rates. Systems Analysis and Improvement Approach: 1. Understanding the cascade from FP clinic enrollment to HIV testing 2. Use process mapping to identify modifiable bottlenecks 3. Define and implement workflow adaptations to eliminate modifiable bottlenecks 4. Monitor change in performance 5. Repeat the analysis and improvement cycle (steps 1-4)
Control Clinics
n=11 FP Clinics
Clinics randomized to the control arm of the study will continue HIV testing as per usual procedures.
Percentage of New FP Clients Who Are Tested for HIV After Year of Minimal Support
61 % tested for HIV
Standard Error 7
19 % tested for HIV
Standard Error 6

Adverse Events

Intervention Clinics

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Clinics

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. R. Scott McClelland

University of Washington

Phone: +206-543-4278

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place